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A total of 150 samples of pig tonsils were collected from slaughterhouse in Abidjan; the pigs were from 
pig farms located in different areas of Côte d’Ivoire. Samples were examined for the presence of Yersinia 
intermedia. Optimal recovery of Y. intermedia was achieved using two step enrichment procedures based on 
pre-enrichment in trypticase soya broth at 28 °C for 24 h, followed by cold enrichment method at 4 °C for 21 
days in phosphate buffered saline broth. Then, Aulisio’s alkali treatment method was performed before 
streaking onto MacConkey agar. Six strains of Yersinia intermedia were isolated and tested for the following 
characteristics associated to the virulence in Y. enterocolitica such as pyrazinamidase activity and 
autoagglutinability. All the six strains were all positive for the pyrazinamidase test and four of them were 
autoagglutinable. Four strains were biotype 4/autoagglutinable and two were biotype 5/O:7,8-8-8,19. All the 
six strains of Yersinia intermedia were rhamnose negative and not motile at 25 °C. The results of antimicrobial 
resistance showed that all the strains presented multiple antibiotic resistance. The results indicate that 4% of 
pig tonsils from different farms collected at the slaughterhouse were contaminated with Yersinia intermedia. 
This study is the first which shows the presence of Yersinia intermedia in pigs in Côte d’Ivoire. 
© 2012 International Formulae Group. All rights reserved. 
 




The name Yersinia intermedia was 
suggested because this species has its 
biochemical and genetic properties 
intermediate to those of Yersinia 
enterocolitica, Y. pseudotuberculosis and Y. 
pestis. The species Yersinia intermedia is a 
member of the genus Yersinia which belongs 
to the Enterobacteriaceae family. Y. 
intermedia was separated from Yersinia 
enterocolitica and was defined biochemically 
and genetically as a new species in 1980. Acid 
production from alpha-Methyl-D-glucoside, 
D-melibiose, D-raffinose and L-rhamnose and 
utilization of Simmons citrate help distinguish 
it from Y. enterocolitica and other Yersinia 
species (Brenner et al., 1980).  
  Bacteria belonging to this species 
have been isolated from the environment 
(freshwater, sewage), various animals (fish, 
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oysters, shrimp, snails, wild and domestic 
animals), food (milk, cream, meat), and 
sometimes, healthy and sick humans, mainly 
from their stools (Martin et al., 2009). 
Y. intermedia apparently are not 
intestinal pathogens, but have been associated 
with wound and skin infections (Bottone, 
1977; Hawkins and Brenner, 1978; Brenner, 
1979). Yersinia intermedia is usually 
considered non pathogenic for humans. 
Therefore, the pathogenic potential of Y. 
intermedia for humans has not been defined 
(Punsalung et al., 1987). 
Besides Y. enterocolitica, two other 
Yersinia species, Y. pseudotuberculosis and Y. 
pestis, have long been known to cause human 
disease (Carniel and Mollaret, 1990; Bottone, 
1999). The remaining seven species (Y. 
intermedia, Y. frederiksenii, Y. kristensenii, Y. 
aldovae, Y. rohdei, Y. bercovieri and Y. 
mollaretii) have generally been termed as "Y.
enterocolitica-like". They have not been 
studied extensively, and because of the 
absence of classical Yersinia virulence 
markers, they have been generally considered 
to be environmental and nonpathogenic 
species. However, an increasing number of 
these non pathogenic species have been 
isolated from sick humans, raising the 
question of their possible pathogenicity 
(Sulakvelidze, 2000). 
The objectives of this work were to 
study Y. intermedia strains isolated from pig 
tonsils in Côte d’Ivoire and to determine their 
phenotype, biotype, serotype and evaluate 
their antibiotic resistance profile. 
 
MATERIALS AND METHODS 
Sampling 
From January 2009 to September 2010, 
a total of 150 samples of pig tonsils were 
collected from apparently healthy pigs at the 
pig slaughterhouse from Abidjan in Côte 
d’Ivoire. The tonsil samples were cut out 
immediately after evisceration and collected 
in sterile plastic bags. The samples were 
stored in an ice box at 4 °C within 2 hours 
during transportation from the site of 
collection and taken to the laboratory for 
immediate processing. 
 
Isolation and identification of Yersinia 
intermedia 
The samples were analyzed at the 
Laboratory of Biotechnology of the 
Department of Biosciences, University of 
Cocody. Tonsil samples were aseptically cut 
into pieces, 10 g per tonsil sample were 
inoculated into 90 ml of trypticase soya broth 
with novobiocin (mTSB-MERCK, Darmstadt, 
Germany) overnight at 28 °C. Then, 0.5 ml of 
TSB broth culture was transferred into 4.5 ml 
of PSMB (Phosphate buffered saline 
supplemented with 1% mannitol, 1% sorbitol 
and 0.15% bile salts), which was incubated at 
4 °C for 21 days. Aulisio’s alkali treatment 
method (Aulisio et al., 1980) was performed 
and immediately streaking onto MacConkey 
agar (BIO-RAD, Marnes-La-Coquette, 
France) supplemented with 1% sorbitol 
(SMAC). The plates were incubated at 25 °C 
for 48 h. After incubation, the plates were 
examined for characteristics colonies. One to 
five small (diameter < 2 mm), transparent or 
pale pink colonies having characteristics of 
Yersinia were transferred onto Trypticase soy 
agar (TSA, Oxoid, France) plates to create 
pure culture and incubated at 25 °C for 24 h. 
All the isolates from pure culture were 
examined for Gram’s staining, oxidase, 
catalase tests, urease activity, tryptophane 
deaminase, glucose fermentation, lactose 
fermentation, H2S production, lysine 
decarboxylase, utilization of Simmons citrate, 
mannitol fermentation, reduction of nitrate 
and motility at 37 °C and 25 °C. The strains 
were further identified by the test of API 20E 
(BioMérieux, Marcy l’Etoile France) 
incubated for 48 h at 25 °C. Isolates identified 
as belonging to the genus Yersinia were sent 
for confirmation of the results and the 
complete characteristics of strains (biotype 
and serotype) at Pasteur Institut, Yersinia 
Research Unit, Yersinia National Reference 
Laboratory, Paris, France. 
 
 




These biochemical tests were 
performed at the French Yersinia reference 
laboratory (‘Centre National des Yersinia, 
Institut Pasteur’, Paris, France).  Biochemical 
tests were performed with API 20E and API 
50CH strips (BioMérieux, Marcy l’Etoile-
France). In addition, biochemical tests based 
on acid production from L-rhamnose, D- 
melibiose, D-raffinose and -Methyl-D-
glucoside and the utilization of Simmons 
citrate were done according to the biotyping 
scheme of Brenner (Brenner et al., 1980). 
 
Serotyping 
This was performed at Pasteur Institut, 
Yersinia Research Unit, Yersinia National 
Reference Laboratory, Paris, France. All the 
strains were serotyped with 53 specific 
antisera. O antigens were detected by slide 
agglutination with the 53 difference antisera, 
according to the typing scheme of Wauters et 
al. (Wauters et al., 1972; Wauters et al., 
1991).  
 
Phenotypic virulence markers 
Pyrazinamidase 
The pyrazinamidase activity was tested 
as described Kandolo and Wauters (1985). 
Strains were inoculated over the entire slant of 
pyrazinamidase agar, inoculated at 28 °C for 
48 h, and tested with 1 ml of fresh prepared 
1% solution of ferrous ammonium sulfate 
(aqueous). A positive pyrazinamidase reaction 
was indicated by a pink to brown color that 
developed on the slant.  
Autoagglutination 
The strains were examined for their 
ability to autoagglutinated at 37 °C in 
trypticase soya broth (Biokar Diagnostics, 
Beauvais, France) as suggested by Kandolo 
and Wauters (1985). Strains were positive if 
autoagglutination occurred when strains 
grown at 37 °C. 
 
Antibiotic susceptibilities testing 
Antibiotic susceptibilities were 
determined by the disc diffusion method on 
Mueller-Hinton agar (Oxoid, France), and the 
results were interpreted according to the 
criteria of the ‘Comité de l'Antibiogramme’ of 
the French Society for Microbiology. The 
plates were incubated (24-48 h at 37 °C) and 
resistance was scared via visual examination.  
The antimicrobial drugs tested and their 
concentrations on the discs (Bio-Rad, Marnes-
La- Coquette, France) were as following: 
Ampicillin (10 µg),  ciprofloxacin (5 µg), 
kanamycin (30 µg), amikacin (30 µg), 
chloramphenicol (30 µg), penicillin (10 UI), 
trimethoprim/sulfamethoxazole (1.25/23.75 
µg), imipenem (10 µg), amoxicillin (25 µg), 
ceftriaxone (30 µg), ceftazidime (30 µg) , 
amoxicillin/clavulanic acid (20 µg/10 µg), 
cephalotin (30 µg), tetracycline (30 UI), 
cefoxitin (30 µg) and ticarcillin (75 µg). 
 
RESULTS 
Sampling and isolation 
From 150 pig tonsil samples, 6 (4%) 
Yersinia intermedia strains were isolated.   
 
Biochemical properties 
All Yersinia intermedia strains gave 
positive reactions for catalase, nitrate 
reduction, ß-galactosidase, ornithine 
decarboxylase, D-glucose, D-mannitol, 
Inositol, D-sorbitol, D-sucrose, D-melibiose, 
amygdalin and pyrazinamidase activity. The 
following tests revealed negative reactions for 
Gram staining, oxidase, tryptophane 
deaminase, lysine decarboxylase, lysine 
deaminase, citrate de Simmons utilization, 
H2S production, arginine dihydrolase, 
gelatinase, lactose, L-rhamnose, gas formation 
from glucose, motility at 25 °C and motility at 
37 °C. All the six strains studied here were 
initially identified as Yersinia enterocolitica 
by an API 20E commercial identification kit 
and finally identified as Y. intermedia at the 
French Yersinia Reference Laboratory 
(‘Centre National des Yersinia, Institut 
Pasteur’, Paris, France).  
 
Biotyping and serotyping of Y. intermedia 
strains 
The six strains of Y. intermedia could 
be divided into two biotypes (biotype 4 and 
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biotype 5). Therefore, four strains of Y. 
intermedia biotype 4/autoagglutinable and 
two biotypes 5/O:7,8-8-8,19 were isolated 
from pig tonsils (Table 1). 
 
Antibiotic susceptibilities 
Antibiograms were determined for the 
six isolates. All Y. intermedia strains were 
resistant to ampicillin, amoxicillin, 
amoxicillin/clavulanic acid, cephalotin, 
penicillin and ticarcillin. They were 
susceptible to ciprofloxacin, kanamycin, 
amikacin, chloramphenicol, trimethoprim/ 
sulfamethoxazole, imipenem, ceftriaxone, 
ceftazidime and tetracycline. The 
susceptibilities of the six Y. intermedia strains 
to 16 antibiotics are shown in Table 2. 
 
 










Mel Rham MG Raf    
A644 IP33928 + - + + - 4 Aag 
A681 IP33929 + - + + - 4 Aag 
A682 IP33930 + - + + - 4 Aag 
A684 IP33931 + - + + - 4 Aag 
A694 IP33932 + - - + - 5 O:7,8-8-8,19 
A700 IP33933 + - - + - 5 O:7,8-8-8,19 
+, positive reaction; -, negative reaction; IP, Institute Pasteur, Mel, melibiose; Rham, L-rhamnose; MG, alpha-Methyl-D-
glucoside; Raf, raffinose; Aag, autoagglutinable   
 
 
Table 2: Antibiotic susceptibilities of Yersinia intermedia strains isolated from pig tonsils. 
 
Antibiotic Disc potency 
Y. intermedia (6) 
Number (%) of isolates 
Resistant Intermediate Sensitive 
Ampicillin  10 µg 6 (100) 0 0 
Ciprofloxacin  5 µg 0 0 6 (100) 
Kanamycin  30 µg 0 0 6 (100) 
Cefoxitin 30 µg 0 1(16.67) 5 (83.33) 
Chloramphenicol  30 µg 0 0 6 (100) 
Penicillin  10 UI 6 (100) 0 0 
Trimethoprim/sulfamethoxazole 1.25/ 23.75 µg 0 0 6 (100) 
Tetracycline  30 UI 0 0 6 (100) 
Amoxicillin/ clavulanic acid  20/10 µg 6 (100) 0 0 
Ceftriaxone  30 µg 0 0 6 (100) 
Imipenem  10 µg 0 0 6 (100) 
Ceftazidime  30 µg 0 0 6 (100) 
Ticarcillin  75 µg 6 (100) 0 0 
Amoxicillin  25 µg 6 (100) 0 0 
Amikacin 30 µg 0 0 6 (100) 









A total of 150 pig tonsils were 
examined for the presence of Yersinia 
intermedia. The strains of Yersinia intermedia 
were isolated in 6 samples (4%) of the tested 
pig tonsils from apparently healthy pigs. 
Likewise, Siriken (2004) examined raw 
ground beef samples and reported that 2 out of 
61 raw beef samples (3.3%) were positive for 
Y. intermedia. In another study by Punsalang 
et al. (1987) isolated 6 Y. intermedia from 860 
stool cultures (0.7%). However, our studies 
generated higher isolation (4%) than the 
results in these studies. Some researchers 
reported that even higher isolation rate were 
detected compared to the results of this study. 
For instance, Nesbakken et al. (1985) in 
Norway and Franzin et al. (1984) in Italy 
found that Y. intermedia were recovered from 
7.9% of retail pork products and 23.3% from 
raw milk. The differences between the 
findings of various authors and those of this 
study might be due to several factor such as 
isolation methods, number of analyzed 
samples, season, and geographical location. 
These factors may cause an increase or 
decrease in the prevalence of the Yersinia spp. 
as Siriken (2004) revealed. In addition, the 
present study was performed in Abidjan, 
where the climate is generally warm. Also, it 
is known that the isolation ratio of Y. 
intermedia is higher in cold climate. The best 
results of isolation were obtained by 
combining pre-enrichment in Trypticase Soya 
broth with novobiocin overnight at 28 °C, 
cold enrichment method in PSMB broth  for 3 
weeks at 4 °C, Aulisio’s alkali treatment 
method and SMAC agar, as previously 
reported by others (Mehlman et al., 1978; 
Doyle and Hugdahl, 1983;  Martinez, 2010). It 
appeared that some enrichment procedures 
were better than others. For example, Jiang et 
al. (2000) reported that the  highest isolation 
rate was 32% for the 4 °C/3-week enrichment, 
followed by 28% for the 4 °C/2-week 
enrichment, 26% for the 25 °C/24-h 
enrichment, 22% for the 4 °C/1-week 
enrichment, and 10% for direct plating. 
Therefore, the isolation ratio may depend on 
the procedure. Furthermore, the identification 
of Y. enterocolitica sensu stricto as Y. 
intermedia by traditional agar plate techniques 
(ISO standard 10273:2003) is complicated by 
the fact that on the commonly used selective 
agar plates, especially the cefsulodin-irgasan-
novobiocin (CIN) agar, several unrelated 
bacteria also grow (Arnold et al., 2004; 
Neubauer et al., 2001). In addition, some 
Yersinia strains are inhibited by CIN agar 
(Fukushima and Gomyoda, 1986). 
In our study, we found that phenotypic 
identification of Yersinia intermedia was 
problematic. All the six strains studied here 
were initially identified as Yersinia 
enterocolitica by an API 20E commercial 
identification kit and finally identified as Y. 
intermedia by Yersinia National Reference 
Laboratory at Pasteur institute. Likewise, the 
six strains of Punsalang et al. (1987) were all 
misidentified as Yersinia enterocolitica by the 
API 20E system and finally identified as Y. 
intermedia. In fact, Y. intermedia was 
proposed by Brenner and his colleagues 
(Brenner et al., 1980) for Yersinia 
enterocolica-like bacteria which are 
rhamnose, melibiose, raffinose and alpha-
Methyl-D-glucoside positive strains. After 
biochemical and DNA hybridization studies, 
these workers subdivided Y. intermedia into 
eight biogroups. Therefore, according to this 
scheme, which is based on the acidification of 
L-rhamnose, D-melibiose, D-raffinose and -
Methyl-D-glucoside and Simmons citrate 
utilization, the six Y. intermedia strains which 
were obtained from pig tonsils in this study 
belong to two biotypes (biotype 4 and 5). 
Biotype 4 was found to be predominant 
among the isolates. All the Y. intermedia 
strains were rhamnose negative and these 
constitute a rare biotype. Also, all the isolates 
were non motile at 25 °C and 37 °C. Unlike, 
most strains isolated in Europe and America 
were motile at 25 °C (Brenner et al., 1980). 
The 6 isolates fit into two biotypes and two 
serotypes, four were biotype 
4/autoagglutinable and two strains of biotype 
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5/O:7,8-8-8,19. In a previous study, Singh and 
Virdi (1999) reported the isolation of Y. 
intermedia biotype 5/O:7,8-8-8,19 in pork 
from India. None of Y. intermedia strains 
examined by Kay et al. (1983), Prpic et al. 
(1985) and Punsalang et al. (1987) were 
autoagglutinable. In contrast to these findings, 
our study reported that four of our six strains 
were autoagglutinable. Likewise, Agbonlahor 
(1986) reported that four of five Y. intermedia 
isolated from patient with diarrhea in Nigeria 
were autoagglutinable. 
Kandolo and Wauters (1985) reported 
that Y. intermedia, Y. frederiksenii, Y. 
kristensenii, the nonpathogenic serobiotypes 
of Y. enterocolitica elaborate the enzyme of 
pyrazinamidase, whereas strains belonging to 
pathogenic biotype do not. This observation 
suggests that examining Yersiniae for 
pyrazinamidase activity could form the basis 
of a useful screening test for virulence. So, the 
pyrazinamidase test was a valuable tool to 
distinguish potentially pathogenic from 
nonpathogenic strains of Yersinia sp. The six 
strains described in our study were all positive 
in the pyrazinamidase test. These results 
indicate that Y. intermedia biotype 
4/autoagglutinable and biotype 5/O:7,8-8-8,19 
didn’t possess the virulence genes usually 
found in pathogenic Yersinia species (lack of 
pyrazinamidase activity). For the present, our 
Y. intermedia isolates should be considered as 
nonpathogenic strains or environment species. 
Although, the strains were usually considered 
to be non pathogenic for humans, it has been 
suggested that they may become host-adapted 
for humans as opportunistic pathogens and be 
clinically significant in the future (Brenner et 
al., 1980; Kay et al. 1983). Otherwise, testing 
for markers of pathogenicity like 
pyrazinamidase activity and 
autoagglutinability provide additional 
information. Markers are not perfectly 
correlated with pathogenicity but provide 
useful information under conditions where 
animal testing is undesirable or impractical. 
Virulence in Yersina enterocolitica is 
mediated by both chromosomal and plasmid-
borne genes.  While chromosomal 
determinants are stable, plasmids containing 
virulence genes may be lost during culture and 
conformational procedures. Temperatures 
above 30 °C are known to cause a loss of 
virulence plasmids in pathogenic Y. 
enterocolitica, but plasmids loss may also 
occur as a result of other less defined 
circumstances (Johnson, 1998). 
Our results generally agree with those 
of others with regard in vitro to 
susceptibilities of ciprofloxacin, kanamycin, 
amikacin, chloramphenicol, trimethoprim/ 
sulfamethoxazole, imipenem, ceftriaxone, 
ceftazidime and tetracycline (Franzin et al., 
1984; Ahmedy et al., 1985). The results of 
antimicrobial resistance showed that the 
strains of Y. intermedia presented multiple 
antibiotic resistances as seen with ampicillin, 
amoxicillin, amoxicillin/clavulanic acid, 
cephalotin, penicillin and ticarcillin. The 
resistance profile of the strains analyzed here 
was similar to those of others studies (Franzin 
et al., 1984; Tzelepi et al., 1999; Stock and 
Wiedemann, 2003). Resistance to ampicillin 
and numerous cephalosporins (cephalotin) 
was common to the strains of Y. enterocolitica 
(Falao et al., 2004). These and related drugs 
are used in veterinary medicine to treat swine 
(Prescott and Baggot, 1988). Therefore, the 
administration of antimicrobial agents for the 
treatment of bacterial infections in both 
veterinary and human medicine poses a 
potential risk because it leads to the selection 
of strains resistant to antibiotics. A high 
incidence of resistant bacteria has particularly 
been reported from developing countries, 
where antibiotics are freely available and their 
use is not subjected to any regulation (Levy, 
1998). The main reason for the increase in 
resistant bacteria population is apparently in 
the application of antibiotics as prophylactics 
and growth stimulants in animals (Aarestrup, 
1999; Teuber, 2001). 
The results of our study showed that 
4% of pig tonsils from different pig farms 
tested at slaughterhouse were contaminated 
with Y. intermedia. The present study supports 
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that swine represent a potential reservoir of 
Yersinia intermedia strains which are possibly 
pathogenic for humans. To our knowledge, no 
report of Y. intermedia isolation from Côte 
d’Ivoire was made before. So, this study is the 
first which showed the existence of Yersinia 
intermedia in our country. 
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